Social and Moral Cognition in Multiple Sclerosis
Social and Moral Cognition in Multiple Sclerosis
We could not find results for this trial
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Socio-demographic questionnaire, moral judgment task, cognitive tests, psychoaffective assessment
- MS questionnaire
- MONTREAL COGNITIVE ASSESSMENT (MoCA) test
What it measured
Main measures
Moral dilemma judgments
3 hours
Other measures (12)
Explicit time perspective inventory test
3 hours
Implicit time perspective inventory test
3 hours
Dot Probe Task
3 hours
Myelin repairThinking and memoryLevel of moral permissibility
3 hours
Level of emotional reactivity
3 hours
Moral relativity level
3 hours
Brief International Cognitive Assessment for Multiple Sclerosis
3 hours
Thinking and memoryThe Beck Depression Inventory
3 hours
Mood and sleepState-Trait Anxiety Inventory
3 hours
Mood and sleepToronto Alexithymia Scale (TAS)-20
3 hours
Who could take part
Relapsing MS · 18 to 55
Show the full criteria
Inclusion criteria
* Men or women aged 18 to 55. * Understanding and able to express themselves in French. * Characteristics according to groups: * MS patient group: * relapsing-remitting form (RRMS) * with EDSS ≤ 4 * with no significant motor, cerebellar or somesthesic disorders of the upper limbs or visual disorders (specific EDSS parameter ≤ 2) * absence of relapse in the last 6 weeks * Control groups: * absence of known global cognitive deterioration. * Understanding and signing of the informed consent and information letter concerning participation in the study. * Beneficiary of health insurance coverage.
Exclusion criteria
* People with previous neurological pathologies, head trauma with loss of consciousness, known psychiatric pathologies (excluding anxiety-depressive syndrome), serious general illnesses, perceptual or dysarthric disorders preventing verbal communication or reading, * Severe cognitive impairment in MS patients, i.e. an SDMT score \< -2.5 if the BICAMS battery is present in the patient's file and is less than 6 months old. * Severe depressive syndrome, with a BDI-FS score > 10 * People with sensory disorders (visual and auditory) that interfere with neuropsychological testing; * Major sensory disorders or cerebellar syndrome * Sensory deficits (visual or auditory) * Treatment with psychotropic drugs * Adults under guardianship, curatorship, persons deprived of liberty. * Pregnant or breast-feeding women
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Multiple Sclerosis (MS) is a chronic, progressive disease that affects young adults (aged between 20 and 40) and has a major impact on patients' quality of life. Cognitive disorders in MS are common, affecting 40-60% of patients. Among these disorders, the presence of social cognition disorders is common. Within social cognition, the moral judgment has been an object of research in order to understand the determinants of moral decision-making: how and why individuals make moral choices with regard to a set of prescriptions and social norms. Compared to control subjects, MS patients show a decrease in moral permissiveness, as well as an increase in moral relativity and emotional reactivity. Thus, it would seem that MS patients issue more deontological choices (lower moral permissiveness). Given that these patients also exhibit empathy deficits and higher alexithymia, these patterns are surprising. Indeed, in other clinical populations, low empathic abilities and high alexithymia are linked to utilitarian rather than deontological moral judgments. The objective of this project is to analyze the process of decision-making carried out by patients during moral dilemma situations in comparison with control individuals and verify whether the presence of a positivity bias could explain the more deontological choices made by some patients. Indeed, some work has shown that older individuals make more deontological moral judgments than younger adults. These results are also observed with young individuals when their future temporal perspectives have been experimentally constrained.
Loading reviews and guidelines…
History
Started
Dec 2023
Main results due
Apr 2025
Finished
Oct 2025